• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Breast Imaging Market

    ID: MRFR/MED/51125-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Breast Imaging Market Research Report By Technology (Mammography, Ultrasound, Magnetic Resonance Imaging, Tomosynthesis, Breast Biopsy), By Product (Systems, Consumables, Software), By Application (Screening, Diagnosis, Treatment Planning) and By End Use (Hospitals, Diagnostic Centers, Research Institutes)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Breast Imaging Market Research Report- Forecast To 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    UK Breast Imaging Market Summary

    The United Kingdom UK Breast Imaging market is projected to grow from 185.3 million USD in 2024 to 298 million USD by 2035.

    Key Market Trends & Highlights

    UK Breast Imaging Key Trends and Highlights

    • The UK Breast Imaging market is valued at 185.3 million USD in 2024.
    • By 2035, the market is expected to reach 298 million USD, indicating robust growth.
    • The compound annual growth rate (CAGR) for the market is projected at 4.41% from 2025 to 2035.
    • Growing adoption of advanced imaging technologies due to increasing awareness of breast cancer screening is a major market driver.

    Market Size & Forecast

    2024 Market Size 185.3 (USD Million)
    2035 Market Size 298 (USD Million)
    CAGR (2025-2035) 4.41%

    Major Players

    Siemens Healthineers, AgfaGevaert, Canon Medical Systems, Meru Health, Kheiron Medical Technologies, Philips, Fujifilm, Radiology Partners, iCAD, Hologic, Sectra, GE Healthcare, Zebra Medical Vision, Qure.ai, Densitas

    UK Breast Imaging Market Trends

    The UK Breast Imaging Market is experiencing significant growth driven by factors such as increasing awareness about breast cancer and the importance of early detection. The UK's National Health Service (NHS) has been actively promoting regular screening programs, which have led to higher participation rates among women. This initiative is crucial given the rising incidence of breast cancer in the UK, with many women now seeking preventive measures. Furthermore, advancements in imaging technologies, like digital mammography and MRI, are enhancing diagnostic accuracy, making them key market drivers in this region.

    There are numerous opportunities to be explored in the UK Breast Imaging Market.

    New developments like the use of artificial intelligence in imaging provide new opportunities for increasing the effectiveness and precision of screenings. In addition, telemedicine and remote consultation services, which became more widespread after the pandemic, improve access to breast imaging services in rural areas. Emerging new areas of medicine, such as personalized medicine and targeted therapies, also open up new possibilities in imaging techniques, which may improve patient outcomes. 

    More recently, healthcare providers' focus on patient comfort and screening experience has increased. There is more provided specifically for women, where, beyond imaging services, emotional support and information are provided concerning the results.The move towards more comprehensive care models, emphasizing the patient journey from screening to diagnosis, reflects changing societal views on healthcare delivery in the UK. The ongoing initiatives to equip hospitals and clinics with cutting-edge technology indicate a robust trend towards modernization in the breast imaging sector in the UK.

    Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

    Market Segment Insights

    Breast Imaging Market Technology Insights

    The Technology segment of the UK Breast Imaging Market is a critical area of focus within healthcare, reflecting advancements in diagnostic imaging techniques and tools used for breast evaluation. This segment primarily includes technologies such as Mammography, Ultrasound, Magnetic Resonance Imaging (MRI), Tomosynthesis, and Breast Biopsy. Mammography continues to play a pivotal role in the early detection of breast abnormalities, making it a vital procedure for routine screening, especially given the UK's National Health Service guidelines promoting regular screening for women over the age of 50. 

    Ultrasound serves as a supplementary tool to mammography, particularly useful in differentiating between cystic and solid masses, hence supporting more precise diagnoses.Magnetic Resonance Imaging (MRI) is increasingly utilized for high-risk patients and cases where mammograms may yield inconclusive results; its ability to provide detailed images of soft tissues and its non-invasive nature significantly enhance diagnostic capabilities. Tomosynthesis, or 3D mammography, represents a notable innovation that helps reduce false positives and minimizes the need for unnecessary biopsies, thus improving patient outcomes and satisfaction. 

    Breast Biopsy remains an essential procedure, allowing for definitive diagnosis when abnormalities are detected, and it employs various techniques, including needle biopsies and excisional biopsies, ensuring that appropriate and accurate treatments can be initiated swiftly.The continuous development and integration of these technologies facilitate better patient care, as they provide more accurate, efficient, and less invasive diagnostic options. However, the segment also faces challenges such as the high costs associated with advanced imaging equipment and the need for trained professionals to operate such technologies effectively. 

    The uptake of technology in the UK Breast Imaging Market is further encouraged by rising awareness of breast health among patients and healthcare providers, coupled with governmental support for initiatives aimed at improving breast cancer detection and treatment. This surge in demand for advanced breast imaging technologies creates a landscape where innovation and efficiency in diagnostic processes are essential to improving overall healthcare outcomes.

    Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

    Breast Imaging Market Product Insights

    The UK Breast Imaging Market is demonstrating significant growth, particularly within the Product segment, which encompasses Systems, Consumables, and Software. The demand for advanced imaging technologies, such as digital mammography systems, is driven by the increasing incidence of breast cancer and heightened awareness among the population, contributing to improved diagnostic accuracy. Consumables, including imaging agents and other supplies, play a crucial role in ensuring the efficacy and reliability of imaging procedures, representing a significant aspect of the market.Meanwhile, Software solutions are becoming integral, facilitating data management, analysis, and workflow optimization, thereby enhancing operational efficiency within healthcare settings. 

    As the healthcare sector in the UK focuses on adopting technological advancements, these components are crucial in shaping the future trajectory of the UK Breast Imaging Market, addressing both clinical needs and patient outcomes effectively. The ongoing emphasis on Research and Development is likely to reflect in a surge of innovations across these areas, responding to the growing demand for personalized healthcare solutions and improving overall screening processes.Furthermore, sustainability and cost-effectiveness also drive the evolution of consumables, pushing manufacturers to develop eco-friendly and economically viable solutions.

    Breast Imaging Market Application Insights

    The UK Breast Imaging Market, particularly within the Application segment, reveals significant insights into the evolving landscape of breast health management. Screening plays a critical role in early detection, comprising various imaging modalities tailored to enhance patient outcomes. With the increase in awareness related to breast cancer, the demand for advanced screening solutions is on the rise, further driving innovations in imaging technologies.

    Diagnosis follows, emphasizing precision in identifying anomalies, which is becoming pivotal as diagnostic imaging continues to evolve with Artificial Intelligence tools.This sub-segment supports healthcare providers in delivering accurate assessments while also aiming to reduce false positives and unnecessary biopsies. 

    Treatment Planning serves a vital function, optimizing therapeutic strategies by utilizing imaging data to guide clinical decisions. The integration of personalized treatment approaches, bolstered by accurate imaging, enhances treatment efficacy and patient satisfaction. Collectively, these Applications reflect the ongoing commitment to improving breast health services throughout the UK, ultimately aligning with public health goals to reduce breast cancer mortality rates.The burgeoning interest in these areas is driven by a combination of technological advancements, increasing incidence rates, and a proactive patient population advocating for advanced diagnostic methods.

    Breast Imaging Market End Use Insights

    The End Use segment of the UK Breast Imaging Market plays a crucial role in the overall healthcare landscape, with prominent settings including hospitals, diagnostic centers, and research institutes. Hospitals typically lead in the adoption of advanced breast imaging technologies, offering comprehensive services that cater to early detection and treatment on a large scale. Diagnostic centers complement this by specializing in imaging services, thus enhancing accessibility and reducing wait times for patients.

    Research institutes are instrumental in pioneering innovative technologies and methodologies in breast imaging, which further fuels market growth and improves patient outcomes.The shift towards digital imaging and the rise of AI in diagnostics represent key trends that are driving transformation within these End Use categories. 

    Challenges such as the need for continuous training and adoption of new technologies showcase the necessity for investment in workforce development. Meanwhile, the increasing prevalence of breast cancer in the UK underscores the urgency for effective imaging solutions, creating substantial opportunities within this market. The diverse End Use landscape illustrates the segmented yet interconnected nature of the UK Breast Imaging Market, highlighting the integral roles different healthcare settings play in enhancing breast health.

    Get more detailed insights about UK Breast Imaging Market Research Report- Forecast To 2035

    Key Players and Competitive Insights

    The UK Breast Imaging Market is experiencing significant growth, driven by advancements in technology, increasing awareness about breast cancer screening, and the growing demand for accurate diagnostic tools. A variety of players within the market are focusing on innovative solutions that improve imaging techniques and enhance patient outcomes. As competition intensifies, companies are investing heavily in research and development to offer state-of-the-art mammography systems, ultrasound equipment, and magnetic resonance imaging tools.

    The landscape comprises both established firms and new entrants, each trying to carve out a niche by differentiating their products and services, thus making the competitive dynamics complex and multifaceted.

    In the UK Breast Imaging Market, Siemens Healthineers holds a prominent position characterized by its comprehensive portfolio of advanced imaging solutions tailored for breast diagnostics. The company's strength lies in its cutting-edge digital mammography systems and tomosynthesis technology, which have set benchmarks for image quality and patient comfort. Siemens Healthineers also benefits from a robust support infrastructure, ensuring that healthcare providers receive timely maintenance and service, which enhances user satisfaction. The company is known for its commitment to innovation, often collaborating with healthcare institutions to understand clinical needs and develop technologies that address specific challenges in breast imaging. 

    This dedication to quality, combined with its strong market presence, allows Siemens Healthineers to maintain a competitive edge in the UK market.AgfaGevaert offers a diverse range of breast imaging solutions that significantly contribute to the UK Breast Imaging Market. The company provides digital radiography systems, electronic patient records, and imaging software that integrates seamlessly with existing healthcare infrastructures, thereby optimizing workflow and improving diagnostic accuracy. 

    AgfaGevaert's key strength lies in its ability to combine diagnostic imaging with data management solutions, creating a holistic approach that appeals to healthcare providers focused on patient care and operational efficiency. The company has also engaged in strategic partnerships and acquisitions to enhance its product offerings and expand its market influence. Through these initiatives, AgfaGevaert aims to strengthen its foothold in the UK, responding effectively to the evolving needs of breast imaging professionals and emphasizing its role in improving outcomes for patients.

    Key Companies in the UK Breast Imaging Market market include

    Industry Developments

    Recent developments in the UK Breast Imaging Market indicate an increasing integration of advanced technologies and innovations aimed at improving diagnostic accuracy and patient outcomes. Siemens Healthineers has made strides with its AI-enhanced imaging solutions, while Philips continues to advance its 3D mammography systems, catering to the growing demand for precise breast cancer detection. In October 2023, AgfaGevaert announced a strategic partnership focused on enhancing digital mammography efficiency through upgraded software solutions. 

    Meanwhile, Meru Health expanded its services for mental health support, recognizing the psychological impacts of breast cancer. Notably, in March 2023, Canon Medical Systems acquired advanced imaging technology aimed at boosting early detection rates in high-risk populations.The market shows significant growth potential, driven by rising awareness of breast health and technological advancements. The UK government is actively promoting early detection, leading to increased investments in modern radiology facilities. 

    In the last couple of years, the introduction of new policies and funding initiatives for breast health education has further stimulated market expansion, positioning companies like GE Healthcare and Hologic at the forefront of this rapidly evolving landscape. Overall, the UK Breast Imaging Market is witnessing robust developments in technology adoption and strategic collaborations to enhance healthcare delivery.

    Market Segmentation

    Breast Imaging Market End Use Outlook

    • Hospitals
    • Diagnostic Centers
    • Research Institutes

    Breast Imaging Market Product Outlook

    • Systems
    • Consumables
    • Software

    Breast Imaging Market Technology Outlook

    • Mammography
    • Ultrasound
    • Magnetic Resonance Imaging
    • Tomosynthesis
    • Breast Biopsy

    Breast Imaging Market Application Outlook

    • Screening
    • Diagnosis
    • Treatment Planning

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 177.65(USD Million)
    MARKET SIZE 2024 185.35(USD Million)
    MARKET SIZE 2035 298.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 4.411% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Siemens Healthineers, AgfaGevaert, Canon Medical Systems, Meru Health, Kheiron Medical Technologies, Philips, Fujifilm, Radiology Partners, iCAD, Hologic, Sectra, GE Healthcare, Zebra Medical Vision, Qure.ai, Densitas
    SEGMENTS COVERED Technology, Product, Application, End Use
    KEY MARKET OPPORTUNITIES Digital mammography adoption increase, AI technology integration for diagnostics, Home-based screening advancement, Enhanced breast imaging for dense tissue, Rising awareness and early detection initiatives
    KEY MARKET DYNAMICS increasing breast cancer prevalence, advancements in imaging technology, government health initiatives, patient awareness and education, insurance coverage expansion
    COUNTRIES COVERED UK

    FAQs

    What is the expected market size of the UK Breast Imaging Market in 2024?

    The UK Breast Imaging Market is expected to be valued at 185.35 million USD in 2024.

    What will be the projected market size of the UK Breast Imaging Market by 2035?

    By 2035, the UK Breast Imaging Market is projected to reach a value of 298.0 million USD.

    What is the compound annual growth rate (CAGR) for the UK Breast Imaging Market from 2025 to 2035?

    The UK Breast Imaging Market is expected to experience a CAGR of 4.411% from 2025 to 2035.

    Which technology segment is projected to have the highest market value in 2035?

    The Mammography segment is projected to have the highest market value, reaching 110.0 million USD in 2035.

    Who are the major players in the UK Breast Imaging Market?

    Key players in the UK Breast Imaging Market include Siemens Healthineers, Philips, Hologic, and GE Healthcare among others.

    What is the market size for Ultrasound in the UK Breast Imaging Market in 2024?

    In 2024, the Ultrasound segment of the UK Breast Imaging Market is valued at 30.0 million USD.

    What expected market size for Magnetic Resonance Imaging in the UK Breast Imaging Market by 2035?

    The Magnetic Resonance Imaging segment is expected to reach 40.0 million USD by 2035.

    What is the growth outlook for the Tomosynthesis segment in the UK Breast Imaging Market?

    The Tomosynthesis segment is expected to grow to 50.0 million USD by 2035 from a value of 30.0 million USD in 2024.

    How will changes in technology impact the UK Breast Imaging Market?

    Emerging technologies in breast imaging are expected to enhance diagnostic capabilities, driving market growth.

    What are the challenges faced by the UK Breast Imaging Market today?

    Challenges include economic constraints and the integration of new technologies within existing healthcare frameworks.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials